e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis
Polzin A., Pletz M., Erbes R., Raffenberg M., Mauch H., Wagner S., Arndt G., Lode H.
Source:
Eur Respir J 2003; 21: 939-943
Journal Issue:
June
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Polzin A., Pletz M., Erbes R., Raffenberg M., Mauch H., Wagner S., Arndt G., Lode H.. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 2003; 21: 939-943
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Procalcitonin (PCT) as a diagnostic tool in lower respiratory tract infections (LRTI) and TB
Source: Eur Respir J 2001; 18: Suppl. 33, 542s
Year: 2001
Diagnostic value of procalcitonin in lower respiratory tract infection
Source: Eur Respir J 2004; 24: Suppl. 48, 187s
Year: 2004
The role of procalcitonin in the differential diagnosis and in the response to treatment of lower respiratory tract infections
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Can Neutrophil/lymphocyte Ratio, C-reactive protein (CRP) and Procalcitonin predict the hospitalization time in patients with lower tract respiratory infections ?
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Can procalcitonin testing reduce antibiotic prescribing for respiratory infections?
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia
Source: Eur Respir J 2005; 25: 688-692
Year: 2005
The usefulness of point-of-care-testing for C-reactive protein in lower respiratory tract infection/acute cough
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012
Treatment of community-acquired lower respiratory tract infections in adults
Source: Eur Respir J 2002; 20: 40S-53S
Year: 2002
Rapid diagnosis of S. pneumoniae by urinary antigen test in children with upper and lower respiratory tract infection
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009
Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Serum levels of LTB4 are increased in patients with lower respiratory tract infection (LRTI) caused by
Mycoplasma pneumoniae
Source: Eur Respir J 2001; 18: Suppl. 33, 542s
Year: 2001
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection
Source: Eur Respir J 2010; 36: 601-607
Year: 2010
The use of C-reactive protein reduces antibiotic prescription for lower respiratory tract infections in primary care
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010
The study of the role of procalcitonin (PCT) in early detection of nosocomial infections in chest patients
Source: Annual Congress 2008 - Mechanical ventilation and airway management
Year: 2008
Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia
Source: Eur Respir J 2006; 27: 253-260
Year: 2006
Diagnostic value of signs, symptoms and laboratory parameters in bacterial lower respiratory tract infection
Source: Eur Respir J 2005; 26: Suppl. 49, 662s
Year: 2005
Interventions to reduce antibiotic prescription for lower respiratory tract infections: Happy Audit study
Source: Eur Respir J 2012; 40: 436-441
Year: 2012
Surfactant protein D (SPD) and C-reactive protein (CRP) in patient with low respiratory tract infections (LRTI)
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
C-reactive protein levels in community-acquired pneumonia
Source: Eur Respir J 2003; 21: 702-705
Year: 2003
High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept